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Spontaneous tumor regression, which is observed 
clinically and histologically in some primary melano-
mas, occurs in the absence of any effective therapy. It 
is probably immunologically mediated, because re-
gressing melanomas are infiltrated with larger num-
bers of activated T cells, primarily CD4+, than non-
regressing melanomas. To investigate the hypothesis 
that spontaneous regression of melanomas is caused 
by T-cell cytokine production, cytokine mRNA ex-
pression in 20 primary melanomas was examined 
using a noncompetitive, quantitative reverse-tran-
scriptase polymerase chain reaction method. DNA 
standards were used to generate known numbers of 
molecules in each sample. Results were standardized 
to the internal control, glyceraldehyde-3-phosphate 
dehydrogenase. mRNA for CD38, lymphotoxin 
(TNF-f3), and IL-2 were significantly elevated in the 
Spontaneous regression is a poorly understood stage of carcinogenesis whereby a tumor partially or completely disappears in the absen ce of effective treatment (Everson and Cole, 1966). T here is considerable evidence that melanomas express tumor rejection antigens and that 
the . immune response controls their growth (Schneeberger et aI, 
1995). Clona l expansion of T cells i.n a regressing melanoma has 
been suggested by the dem onstration of limited T -cell receptor 
/3-chain usage (Ferradi.l1.i et aI, 1993). Previous studies by our group 
have shown that regressing melanomas, basal cell carcinomas, and 
keratoacanthomas are infi.ltrated with larger numbers of activated T 
cells, m ainly CD4+, than nonregressing tumors (Tefany c/ aI, 1991; 
Halliday et aI, 1995). We hypothesized that these CD4+ T cells 
were responsible for the process of regression by secreting a 
particular cytokine profile and thus undertook an analysis of the 
cytokine mRNA expression of regressing and nonregressing pri-
m ary melanomas. 
Cytokin e responses have been broadly categorized into two m ain 
types. T helper 1 (Thl) cytokines include interleukin-2 (IL-2) , 
i.l1.terferon-y (IFN-y) , and lymphotoxin [tumor necrosis £1ctor-/3 
(TNF-J3)) and are responsible for cell-mediated inlmuluty. Th2 
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ten regressing melanomas compared to the ten non-
regressing melanomas. IFN-y mRNA was also ele-
vated in regressing melanomas but failed to reach 
statistical significance. The Th2 cytokines IL-10 and 
IL-13 did not show differences in the regressing mel-
anomas compared to nonregressing melanomas; nei-
ther did the pro-inflammatory cytokines IL-1a, IL-
11l, IL-6, IL-8, and TNF-a, nor the growth factors, 
bFGF and TGF-Il or GM-CSF. This study shows an 
association between Th1 cytokines and spontane-
ously regressing melanomas. Although we have not 
shown that these cytokines cause regression, these 
findings support our hypothesis that activated CD4+ 
T cells may mediate melanoma regression by secre-
tion of Th1 cytokines. Key words: lympltotoxillJinterlelt-
kin-2/skin cancer/tumor regression. ] Invest Dermatol 108: 
914-919, 1997 
type cytokin es, IL-4, IL-5 , IL-6, IL-10, and IL-13, are capable of 
stimulating humoral immunity (Mosmann et aI, 1991; Kelso, 1995). 
This concept of categorization of cytokine responses, however, 
may be an oversimplification of dynamic biologic system s. T hl and 
Th2 extreme phenotypes may represent ends of a spectrum of 
distribution of cytokine secretion rather than discrete cellular 
subsets (Kelso, 1995). 
In a comparison of ten basal cell carcinomas and seven irritated 
seborrheic keratoses using reverse-transcription polymerase chain 
reaction (RT-PCR), mRNA for lL-4, IL-5 , IL-I0, and granulo-
cyte-macrophage colony stimulating factor (GM-CSF) was higher 
ill basal cell carcinomas, and IL-2, IFN-y, and lymphotoxin were 
more strongly expressed in seborrheic keratoses (Yamamura c/ aI, 
1993) . This supports a Thl pa.ttern of cytokin e mRNA expression 
in the benign seborrheic keratoses and a T h2 pattern in a malignant 
tumor group, the basal cell carcinomas. 
To determine whether Thl, Th2, or other cytokines are involved 
in spontaneous regression of prinlary m elanomas, we have com-
pared the cytokine mRNA profile of ten regressing and ten 
nonregressing primary m elanomas using a noncompetitive quan ti-
tative RT-PCR. We chose to determine the mRNA profile using 
the very sensitive m ethod ofR T -PCR because it is possible to study 
a large panel of cytokin es with the limited amount of material 
available from these lesions, and it allows identification of cytokines 
with low expression . 
MATElUALS AND METHODS 
Melanoma Collection Forty four primary melanomas were collected 
from the Sydney Melanoma Unit at Royal Prince Alfred Hospital from 
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March 1993-April 1995. Specimens were not collected for tlus study if the 
lesion was recurrent or if the patient "vas an organ transplantation recipient, 
immwlOsuppresscd, 01' had a lustory of prior chemotherapy. Ulcerated 
lesions were not included in the study unless the tumor was large and the 
area of ulceration could be avoided . In all cases, informed consent was 
obtained according to the guidelines of the Central Sydney Area H ealth 
Service Human Ethics Committee. A 3- to 6-ml11 punch biopsy was 
obtained from the lesion as soon as possible after surgery, map-frozen, and 
stored in liquid lutrogen until required. The remainder of the tumor was 
formalin fixed and paraflin embedded for routine h..istologic examination. 
For the purposes ofth.is study, a tissue section was cut to include the punch 
biop sy sitc so that the melanoma could be lustologicaUy assessed on each 
side of the piece of tissue removed for cytokine studies. 
Nonnal Skin Collection Samples of normal human skin were obtained 
during removal of clinically benign nevi .in the dermatology biopsy clinic at 
Royal Prince Alfred Hospital. The ends of the ellipse were removed and 
snap-frozen immediately. T he sample was included only if ti, e lesion was 
benign and its margins were clear. 
Classification of Melanonla The melanomas were classified according 
to subtype (superficial spreading melanoma, nodular melanoma, lentigo 
maligna melanoma). Additional information recorded for each melanoma 
included Breslow tluckness, Clark's level, and mitoses per 111m2 • Classifica-
tio n of regression was performed by one pathologist (KC.). Regression was 
reported as present or absent. If present, it was further divided UltO early, 
intermediate, or h,te regression using the fo llowing criteria (McGovem, 
1975). In carll' regression, a lymphocytic infiltrate penetrates and disrupts 
the tumor cells, and degenerating tumor cells may be seen. As ti,e process 
continues , angiogenesis and fibroblast proliferation occnr, with a variable 
lymphocytic infiltrate (intermediate regression). In late regression, ti,e 
lymphocytic infiltrate is very slight or disappears, tumor is absent or sparse, 
and fibrosis and variable numbers of new blood vessels appear. The 
determining area for classification of regression was the region surroundulg 
the punch biopsy site, and by examuung closely the region adjacent to the 
tissue analyzed for mRNA, we were able to ascribe each tumor to a group 
that should best describe ti,e process occurring Ul the biopsy specimen. The 
regressulg group comprised specimens showing early and intermediate 
regression; those with late regression were excluded from cytokinc analysis. 
The late-regressing specimens were not included Ul tlus study because their 
cyrokllle profile might have been mOre reflective of a wound-healing 
process and may have differed from the cytokine profile of active regression. 
Specimens without features of regression were included Ul the nonrcgress-
mg group . 
Total RNA Extraction and COnlplcmcntary DNA (cDNA) Synthesis 
Total RNA was prepared by acid guanidinium tlliocyanate-phenol-chloro-
fonn extraction (Chomczynski and Sacchi , 1987; Bishop et ai, 1993). 
Melanin contanunation of some RNA specimens was noted. Its contribution 
to errors in RN A estimation by OD260 measurement was corrected for using 
a standard curve of melalun absorbance at OD260 and OD 400' One 
rn..icrogram of biopsy RNA was reverse transcribed using Superscript RNase 
H - enzyme kit (GIDCO BRL. Gaithersberg, MD) with Oligo dT (Boehr-
inger Mannheim, Mannheim, Germany), as previously described (Bishop et 
01, 1993). A negative control consisted of a cDNA synthesis reaction 
omitting the reverse transcriptase enzyme (mu1lIs R T control). cDNA 
synthesis was performed in duplicate, named cDNAl and cDNA2. 
Noncompetitive Quantitative PCR PCR reactions were performed as 
previously described (Bishop et aI, 1997). Each primer pair was optimized 
for MgCI2 and Taq DNA polymerase concentrations and PCR. amplification 
conditions. The PCR. qu,mtitation metbod of Dalmlan et al (1991) was 
modified to include extel11al cytokine standards (Napoli et ai, 1996; Bishop 
et ai, 1997). PCR product aliquots of 4.5 f.LI were removed from tile samples 
and the standards every two cycles, for most cytokines from cycle 26 
onward. Aliquots were transferred to Hybond N + nylon membrane (Am-
eesham, Little Chalfont, UK) using a dot-blot vacuum apparatus (Bio-Rad, 
Richmond, CA) and membranes hybridized with a I'-ATP-33 p (DuPont, 
Boston, MA) end-labeled hybridization pl;mer. Washed membranes were 
exposed to a phosphor imagillg plate (Fuji Photo Film, Tok]'o, Japan) and 
scanned on a Fujix Bio-imaging analyzer BAS 1000 (Fuji", Tokyo, Japan) , 
and radioactivity in each dot was integrated (Bishop et ai, 1997, Napoli et ai, 
1996). T he number ofmolecuJes ofcytoki.l1e cDNA for each specimen was 
calculated by the use of a standard curve prepared from the known number 
of molecules included in each run, as previously described (Napoli et ai, 
1996; Bishop et ai, 1997) . The reproducibility of ti,e RT-PCR reaction was 
assessed by PCR amplification of cDNA 1 and cDNA 2. 
The oligonucleotide cytokine primers used for IL-l/3, IL-2, lL-6, IL-8 , 
IL-10, IFN-I', TNF-c<, and transformulg growth factor-/31 (TGF-/31) have 
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been published (Bishop et ai , 1993; Napoli et al. 1994), as have tlIOse used 
for IL-4 and GM-CSF (Ehlers and Smith, 1991) and CD3B (Yamamura et ai, 
1991). Sequences in brackets show an EcoRl restriction site. The predicted 
product size in base pairs (bp) for each set of prullers is indicated. 
Glyccraldehyde-3-phosphate dehydrogenase (G3PD) forward: 5' GAA 
GGT CGG TGT CAA CGG ATT TGG 3'. G3PD reverse: 5' CAG TTG 
GTG GTG CAG GAT GCA TTG 3' (456 bp). G3PD hybridization: 5' CAC 
CAT CTT CCA GGA GCG CGA TCC 3'. lL-la forward: 5' GAA GGC 
TGC ATG GAT CAA TCT GTG TC 3'. IL-1a reverse: 5' TGA GGG CGT 
CAT TCA GGA TGA ATT C 3' (289 bpi. lL-1a hybridization: 5' CGC 
CAA TGA CTC AGA GGA AGA AAT C 3'. LYl11photoxin forward: 5' 
(AAG/AAT TC) AAC GTC TCT TCC TCC CAA GGG TGT G 3 '. 
Lymphotoxin reverse: 5' GTT CTG CTT GCT GGG GTC TCC AAT G 
(212 bp) 3'. Lymphotox..in hybridization: 5' (AAG/AAT TC) GTI GCT 
GTG GGC AAG ATG CAT CTT G 3'. Basic fibroblast growth factor 
(bFGF) forward: 5' TAC TGC AAG AAC GGC GGC TTC TTC 3'. bFGF 
reverse: 5' TAC TGG CCA GTI CGT TIC AGT GCC 3' (302 bpi. bFGF 
hybL;dization: 5' GCT GCT GGC TTC .TAA GTG TGT TAC 3'. IL-4 
hybridization: 5' TIC ACA GGA CAG GAA TTC AAG CCC 3'. GM-CSF 
hybridization: 5' TTT GAC CTC CAG GAG CCG ACC TG 3'. CD3B 
hybridization: 5' GCT CTG GCA CAT TCG ATA ATG 3' . 
Statistical Analysis Nonparametric tests were used to test for signifi cant 
differences as the data were not nonnaHy distributed. The Speanl1an rank 
correlation coefficient was used for linear regression analysis of cDNA 
syntheses, and the Man.n Whitney U tcst was used for melallOma group 
analysis. A p value of < 0.05 was rega.rded as significallt. 
RESULTS 
Classification of Non regressing and Regressing Melanomas 
Of the 44 primary melanomas collected from 43 patients, 20 were 
suitable for analysis in this study. The remaining primary melano-
mas, which were not analyzed, included those with late regression; 
lesions with extensive ulceration; cases with dual pathology, e.g., 
melanoma and basal cell carcinoma; a desmoplastic melanoma; 
cases in which the punch biopsy did not appear to include 
melanoma, and a few C,lses in which the classification of regression 
status was equivocal . Only one biopsy was used from the patie nt 
with two pt;maries. 
The cha.racteristics of the primary m elanomas used in this study 
are presented in Table I. Twenty tumors were used, ten demon-
strating features of early co intermediate regJ:essiOll, and ten n011-
regressing melanomas. The regressing group h ad a slightly lower 
average age of 57.6 Y ( :1: 16.4) compared to 62.4 y ( :I: 14.1) fOT the 
nonregressing group. T h e male:female ratio in the regressing 
melanomas was 7:3, and this was reversed in t1l.e nonregressing 
group. There were more primary nonregressing melanomas 011 t11e 
lower limb but more regressing lesions on the trunk. Except for one 
lentigo maligna melanoma and one nonclassifiable lesions both in 
the nonregressing group, all lesions analyzed were superficial 
spreading melanomas. 
The median Breslow t1uckness and median C lark's level , wluch 
are important prognostic indicators, were lower in the regressing 
group. The median Breslow thickness in the nonregressing group 
(2.03 nun) was twice the median of the regressing group (1.05 
mm). T he median Clark's Level for the nonregressing group was 
III-IV (II-IV), whereas the regressing group was III (I-V). Tlus 
suggests a better prognosis; however, the process of regression can 
alter the architecture of the melanoma and make these character-
istics difficult to interpret. 
The median mitotic count per mm2 was similar for bOtl1 groups. 
One lesion in each group had i.nsufficient dermal tUl110r for a 
nutotic count. One nonregressing and tV,TO regressing melanomas 
were associated with an area of ulceration. Tlus area was avoided 
during biopsy sampling. Four regressing and three nonregressing 
melanomas were associated w ith a nevus. All patients were clinical 
stage I at the time of tumor collection, but one patient from each 
group had cutaneou s metastases and one patient in the nonregress-
ing group was pathologic Stage II, with two of 18 draining lymph 
nodes positive at the time of presentation. 
Cytokine mRNA Analysis cDNA products w e re of predicted 
size by ethidiu111 bromide-stained gel electrophoresis. Minus RT 
916 LOWES ET AL T HE JOURNAL O F INVESTIGATIV E DERMATOLOGY 
Table I. Clinical and Histopathological Comparison of Regressing and Nonregressing Primary Melanomas 
Regressing Melanomas NOllfcgressing Melanomas 
Total number: 20 
Mean agc (::':: SD) 
Sex (M:F) 
Site 
10 
57 .6 Y ::':: 16.4 
7:3 
Trunk: 5 
Upper limbs: 4 
Lower limbs: 0 
Head and neck: 1 
10 
62.4 Y ::':: 14.1 
3:7 
Trunk: 2 
Upper limbs: 1 
Lower limbs: 6 
Head and neck: 1 
Mehllloma classification Superficial spreading melanoma: 10 Snperficial sprcading melanoma: 8 
Lentigo maligna 111clnnolna: '1 
Non-classifiab le: 1 
lIJ (I "-V) Ill-IV (II-IV) MedialJ Clark's level (range) 
Median Breslow thiclmcss (range) 
Median mitoses/mm2 (range) 
Ulceration 
1.05 mm (0.35-11 111m) 
1.0/mm2 (insufficicnt"-6) 
2 
2.03 mm (0.52-15 111m) 
1.0/l11m2 (insnflicient"-1. 5) 
1 
Associatio ns 
Clinical stagc 
nevus: 4 
I' 
nevus: 3 
I,ll 
" O ne sample showed evidence of regression o f the dermal com ponent mid was C lark 's level I. 
/, Insufficient mitoses denotes insufficie nt dermal tumor for a mitotic count. There was one of these cases in each group and these were not included in the calculations. 
r O ne patient in each group had cutaneous metastases at the time of presentation. 
II O nc patien t had clinical stage I disease but pathologic st:tgc II disease (2/18 draining lymph nodes positive) at the time of presentatiol1 . 
con tro ls were negative for all cytokines. T he quantitative method 
described here showed good reproducibili ty, with high correlations 
between cDN A 1 and cDNA 2. 
G3PO Figure 1 shows the dot blot PCR for G3PD (a), and 
radioactive counts vers lls cycle number for G3PD standards (b) . 
G3PD was used as a positive internal control to correct for the 
amount and stabili ty of mRNA between specimens. There was a 
good correlation between cONA 1 and cDNA 2 for G3PD (p < 
0.001). T here was no statistical difference in G3PD between the 
tumor gro ups or between the regressing group and normal skin 
(Fig Ie) . T he regressing melanoma group contained a median 
number of molecules of G3PD of 470,793 (range 
29,768-1,541,275), w hich was not significantly different from 
nonregressing m elanomas, which contained a median of 628,740 
(range 267,789-1,999,243), or normal skin, which contained a 
median 306,3 18 (range 148,146-404,387). 
C030 T he ratio of the number of molecules of CD30 mRNAI 
G3PD is show n in Figure 2 . There was a good correla tion between 
cDNA 1 and cD NA 2 for CD30 (p < 0.01). T he regressing 
m elanoma group contain ed a median of 7,553 (range 1,172-
35,091), w hich was signifi cantly higher than both the nonregressing 
group , which had a median ofl,527 (range 93-18,130) (p < 0.05), 
and the normal skin, which had a median of 151 (range 136-348) 
(p < 0.01). 
Th1 Type Cytokine mRNA Expression T he ratio of the 
number of molecules ofThl cytokine mRNA/G3 PD are shown in 
Figure 3. T here was a good correlation between cDN A 1 and 
cDNA 2 for the Thl cytokines (p < 0.01). T he median result for 
Iymphotoxin in the regressing group of melanomas was 971 (range 
288-3216), which was significantly elevated in comparison to the 
nonregressing m elanomas, which had a median of 351 (range 
44-2063) (p < 0.05). T he median number of molecules of 
Iymphotoxin in normal skin was 431 (range 88-1165), which was 
not significantly differen t from the regressin g group. T he regressing 
group of m elanomas also contained significantly more IL-2, with a 
median of82 (range 26 - 812), compared to nonregressing melano-
mas, which had a m edian of 36 (range 0-1127) (p < 0.05), and 
nornlaJ skin , which had a m edian of 7 (range 0-33) (p < 0.01). 
IFN- ")' was elevated in the regressing group of m elanomas, with a 
median of 338 (range 0-5185). but not significantly, when com-
pared to the nonregressing m elano ma group, which had a rpedian 
of 273 (range 60 -7049). N ormal skin had a median of 173 (range 
77-291) for IFN- ")" which was not significantly different fro m that 
of tile regress ing m elano mas. T he apparently greater amount of 
Iymphotoxin mRNA in normal skin compared to tlle other Thl 
cytokines may not be significant due to the low sample size of this 
group and tile difficulty of comparing absolute numbers of mole-
cules of one cytokine with another when using differen t cytokine 
primer pairs. 
Th2 Type Cytokine mRNA Expression T here were no dif-
ferences in the number of molecules of mRNA for IL- I0 or IL-1 3 
in the tumor groups or normal skin (Fig 4). T here was a good 
correlation between cDNA 1 and cDNA 2 for the T h2 cytokines 
(p < 0.01) . Median number of IL-I0 mRNA mol ecules in regress-
ing melanomas was 2307 (range 0-6751) compared to 1800 (range 
534-53 24) for nonregressing melanomas and 2590 (range 654 -
8823) .in normal skin . Medi an number of molecules of lL-13 in 
regressing mel31l0maS was 2 (range 0 - 37), in nonregressing mela-
nomas it was 2 (range 0 - 81), and in normal skin it was 7 (range 
3-1 2) . lL-4 was particularly difficult to ampli fy consistently, despite 
using undilu ted cDNA, probably due to its low expression. 
Pro-inflammatory Cytokines, Growth Factors, and GM-
CSF mRNA Expression N one of the other cytokines investi-
gated, IL-la, TL-IJ3, IL-6 , IL-8, T N F-a, GM-CSF, TGF-J3, or 
bFGF, showed significant differences between regressing and 110U-
regressing mel31l0maS (Table II). IL-8 was significantly elevated in 
the regressing melanomas compared to normal skin (p < 0.05) , but 
no other cytokines in this group were significantly different in 
normal skin compared with regressing m elan omas. 
Correlation of Cytokine and C030 mRNA The ratio of tile 
number of m olecules of cytokine mRNA/G3PD for Th 1 cytokines, 
bu t not T h2 cytokines, showed significant positive correlations 
with CD38 mRNA. There were positive Spearman rank correla-
tions for CD30 3lld Iymphotoxin (p < 0.01), IL-2 (p < 0.01), and 
IFN -")' (p < 0.05) . Of the other cytokines and growth factors 
an alyzed, IL-8 showed a positive correlation with CD30 (p < 0.01) 
as did bFGF (p < 0.05), and TGF-J3 showed a negative correlation 
(p < 0.01). 
Relationship between T-Helper Cytokines for Individual 
Melanomas To determine whether individual melanomas were 
always producing high levels of each T-cell cytokine or whether 
some tumors had a reciprocal re lationship between T hl and T h2 
cytokine production , the ratio of the number of m olecules of 
TNF-J3 mRNA/G3PD was correlated with tile other T hl and Th2 
cytokines by linear regression analysis. TNF-J3 showed a positive 
correlation with IL -2 (p < 0.01), bu t not with IFN-"), (p = 0.07) , 
IL-10 (p = 0.21), or IL-13 (p = 0.6). 
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Figure 1. Noncompetitive quantitative RT-PCR for G3PD in mel-
anomas. (a) Dot-blot PCR for G3PD for melanomas (MM) and nom,,] 
skin. An aliquot of the PCR reaction mix was removed every two cycles 
(labeled on lift a.xis) and dotted in a row underneath for each specimen. 
Standards were rWl concurrently (shown on right). (b) Radioactive counts 
versus cycle for G3PD standards. Logarithm ic dilutions of molecules of 
G3PD DNA standards (107-104 ) were added at we start of the PCR and 
amplified concurrently with we samples. (c) Number of molecules ofG3PD 
eDNA per 0.025 !J-g RNA in regressing melanomas (reg MM) and 
nonregressing melanomas (non-reg MM) . Each symbol corresponds to a 
single tumor; the same symbols are used for a particular sample in each 
figure. No significant differences (Mann Whitney U test) were found 
cotnpared to regressing melanomas. 
DISCUSSION 
The study of cytokines in spont311eously regressing primary mela-
nomas could improve our understanding of this important biologic 
phenomenon and aid in designing more effective therapeutic 
interventions. Our method of RT-PCR was developed to deter-
mine more clearly the diffe rences in cytokine mRNA production in 
tumor biopsies. The original system of Dallman was quantitated 
visually from the dot-blot (Dallman et ai, 1991; Bishop et ai, 1993 ; 
Napoli et ai, 1994). We subsequently produced our own DNA 
standards for inclusion in each PCR run (Napoli et ai, 1996). 
CD38 is expressed only on T cells, where it is intimately 
associated with the T -cell receptor. T he low level ofCD38 mRNA 
we observed in normal skin is in agreement with previous findings 
o'f low numbers ofT cells in normal skin. T here was a signific311t1y 
increased level of CD38 in regressing m el3110mas compared to 
nonregressin g lesions. Tlus is consistent w ith immunolustochemical 
analysis of the inflanunatory infiltrate in primary melanomas by 
Tefany et ai, w hich showed a 3 .5-fold increase in the median of 
CD3-positive cells in regressing lI erSllS nonregressing melanomas 
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Figure 2. CD38 is elevated in regressing melanomas (reg MM) 
compared to nonregressing melanomas (non-reg MM). Ratio of 
number of molecules CD30 mRNA/ G3PD. Each S)~11bol conesponds to a 
single tumor, and the same symbols arc used for a particular samplc in each 
figure. p values (Malln W hitney U test) compared to regressing melanomas. 
(Tefany et ai, 1991). This is similar to our results at the mRNA 
level, which were 5- fo ld higher in regressing melanomas. 
We have investigated th e cytokine profile of fresh primary 
regressing and nonregressing melanomas. Few studies h ave eX3111-
ined cytokine expression in primary mel3110mas. One study 311a-
Iyzed 20 fresh m elanomas (seven primary and 13 metasta tic) for 
tll eir cytokine profde by RT -PCR (Ciotti e/ ai, 1995). In the 
primary m el3110mas they found mRNA for IL- la (43% of samples 
positive), IL- l{3 (71 %) , IL- 6 (43%), IL-8 (86%), 311d bFGF (71 %) . 
GM- CSF was found in no primary lesions. Our resul ts confirm the 
presence of all these cytokines in primary m elanomas but extend 
these studies to show that only IL-2 and IL-8 are significantly 
lugher in regressin g melanomas th311 in normal skin . IL- 8 h as been 
shown to be produced by tile majority of melanomas 3l1d may b e an 
autocrine growth factor (Anllstrong et ai , 1995). The correlation 
between IL-8 and CD38 is intriguing 3l1d suggests th at T cells 
directly or indirectly may result in 311 increase in IL-8 production. 
IL-8 has been correlated with growth and m etastasis ill a murine 
model (Sin gh et ai, 1.994), implicating inflammatory cells in the 
p romotion of tumor growth. 
R eed et al have examined a large group of melanocytic lesions, 
including primary m elanomas, for bFGF (Reed ct ai, 1994a) and 
TGF-{3 (Reed et ai, 1994b) by nucleic acid ill situ hybridization. 
Invasive mel3l10mas and ill sitll melanomas with features of regres-
sion were positive for bFGF. Forty one percent of C lark level n 
mel3110mas and 94% of Clark level III, IV, or V mel3l10mas w ere 
positive for TGF- {3. In sit ... melanomas were negative for both these 
growth factors. T heir results suggest that bFGF and TGF-{3 may be 
involved in tumor invasion rather than malignant transformation. 
bFGF is produced by many cell types, including melanomas, and 
some studies suggest it may function as an autocrine growtll factor 
(Herlyn , 1993). Because of the role of bFGF in angiogenesis 
(Herlyn , 1993) , it may have a ro le in tumor neovascularization, o r, 
in regressing melanomas, it may be associated with angiogenesis in 
scar ti ssu e formation. TGF-{3 may have 311 immunosuppressive 
function conferring a growth advantage on the tumor by modulat-
ing host T -cell responses (lnge et ai, 1.992). Its n egative correlation 
with CD38 in these studies may be quite significant in view of the 
T - cell-immunosuppressive role of TGF-{3. 
Metastatic tumors are likely to differ in their cytokine profile 
compared to primary lesions, and these d.ifferences may reflect the 
m etastatic process. The main difference is that metasta tic m elano-
mas appear to contain low levels of the T h1 cytokines, IFN-')! and 
IL-2, but relatively lugh levels ofTGF-{3 and GM-CSF (Luscher et 
ai, 1994; Ciotti e/ ai, 1995). T IllS contrasts with our findings of 
increased T h l cytokine mRNA for lymphotoxin, IL- 2, and IFN-,)!, 
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Figure 3. Thl cytokines were elevated in regressing melanomas 
(reg MM) compared to nonregressing melanomas (non-reg MM). 
Ratio of number ofmoleellies (mol) oflymphotoxin (a) , lL-2 (b), and IFN-y 
(e) mRNA/G3PD. Each symbol corresponds to a single tumor, and the same 
symbols are used for a particular sample in each figu re. p values (MaIUl 
Wh.itney U test) compared to regressing melanomas. 
in regressing compared to nonregressing m elanomas and also 
suggests that TGF-f3 may inhibit T-cell inEItration . It is possible 
that, compared to nonregressing primary m elanomas, regressing 
lesions may have an activated loca l immune response and metastatic 
tumors may have a suppressed response, and tlus is reflected in their 
opposite cytokine mRNA production . 
LymphotoA'in is primarily produced by actj.vated T cells (Paw and 
Ruddle, 1988), but can also be produced by some nonlymphoid 
cells including melanocyte and m elanoma cell lines (Melani et ai, 
1993). This cytokine has been shown to be anti-carcinogenic in vitro 
(Browning and Ribolini, 1989) and is a potent anti-tumor and 
anti-metas tatic agent against Meth A tumors in syugeneic mice 
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Figure 4. Th2 cytokille~ in regressing melanomas (reg MM) we e 
not different from those in nonregressing melanomas (non-reg 
MM). Itatio of number of molecules of IL-I0 (a) and IL-13 (b) mR.NAI 
G3PD. Each symbol corresponds to a single tumor. and the same symbols 
are used for a particular sample in eacb ftgure. No significant differences 
were found compared to regressing melanomas (Mann Whitney U test). 
(Funahashj et ai, 1991). In nude mice it h as a much less potent local 
effect and negligible anti-metastatic activity (Funahashi et ai, 1991) . 
A plasmacytoma transfected with lymphotoxin was rejected in a1 
complex manner involving both B and T lymphocytes as w ell as 
macrophages (Qin and Blankenstein, 1995). 
IL-2 was significantly elevated, and IFN-y nonsignificantly ele-
vated, in our regressing group of m elanom as. IL-2 is produced by 
T cells and is very important in the activation phase of immune 
respon ses, leading to activation and proliferation of effector T cells 
(Hill et ni, 1992) . ft is a well characterized anti- tumorigenic 
Table II. Pro-inflammatory Cytokines, Growth Factors 
and GM-CSF mRNA" 
Cytokinc" RegMM Non-Iteg MM Normal SkUl 
IL-l e> 185 (24-351) 75 (15-602) 511 (66-873) 
IL-1{3 820 (0-4865) 248 (30-3209) 1455 (74-351 5) 
LL-6 421 (0-16333) 2072 (0-165050) 74 (0-148) 
IL-8 501 (27-2520) 225 (52- 8815) 25 (11-42)' 
T NF-e> f>lS (133-1 899) 389 (9-948) 728 (234 -1188) 
GM-CSF 1014 (0-9491) 592 (336 - 10028) 917 (124-1870) 
TGF-{3 319 (0-22568) 630 (0-12773) 9161 (752-53580) 
bFGF 107 (35-530) 80 (11-397) 7 (42-91) 
" Mcdjan ratio of the number of mo lecules of cytokine mRNA/G3PD (range) in 
regressing melanoma (Reg MM) (0 = 10) . nonregrcssing I11 c l ar~oma (non-reg MM) 
(n = 10). al]d normal skin (n = 4). . 
II No significant differences between regressing :lI1d non regressing melanoma for any 
cytokinc (Mann Whitney U test). 
f' There was significau t1 y less lL-8 in 110 nnal skin compared to the regressing group 
(p < 0.Q5) (Mann W lutncy U test). 
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cytokine, which has been used in clinical protocols to treat 
melanoma (Hill el ai , 1992). IFN-")" which is also primarily 
produced by T celis, may be directly cytolytic to tumor cells ill "itm 
(Tyring et ai, 1982) and has significant indirect anti-tumor roles 
(Hill et ai, 1992). 
Th2-type cytokines favor humoral responses at the expense of 
cell-mediated immunity (Mosmann et ai, 1991), but the Th2 
cytokines rL-I0 and IL-13 were not reduced in regressing com-
pared to nom'egressing m elanomas. There was no inverse relation-
ship between Th2 cytokines and the Thl cytokine Iymphotoxin, 
indicating that Th2 cytokines do not appear to inh.ibit Thl cytokine 
production in these meianOlnas. 
Our results suggest that nonlymphoid inflamniatory cells are not 
responsible for regression of melanomas. Macrophages have been 
found in regressing melanomas (Brocker et ai, 1990), but there was 
no difference in MHC Class II expression (Tefany et ai, 1991). If 
macrophages were important mediators of regression, we would 
have expected to observe a different profile of cytokines to that 
which we obtained. We did not see a pro-inflammatory pattem of 
cytokines, suggesting that these responses are not a prerequisite for 
regression. 
This study did not directly determine the cell type responsible for 
cytokine secretion or prove that Thl cytokines caused the regres-
sion. Despite the sensitivity ofRT-PCR, we may have been unable 
to detect small differences in local cytokine secretion. Our study 
provides information, however, regarding the quantitation of the 
cytokine mRNA profile of a large group of primary melanomas and 
four normal skin samples. CD4+ Thl cytokines, Iymphotoxin and 
IL-2, were significantly increased in regressing melanomas, and 
IFN-")' was nonsign.ifican tly elevated. We found no differences 
betw"een the tumor groups for any of the Th2 cytokines, which 
suggests that t11ese cytokines do not inhibit regression. There were 
no significant differcnces betwecn tWllor groups for an y of the 
other cytokines and growth factors studied. This cytokine profile of 
regressing melanomas is a Thl. pattem, and these cytokines corre-
lated with the increased CD38, which strongly supports an active 
role for CD4+ T cens in spontaneous regression of melanoma. 
We are grattflll to PI"OJesso,. HI.H. lvEcCm11,y alld tllc staff ill tile Sydlle)' MelmlO lI/ a 
Unit al Royal PrillCC Alfred Hospital Jo ,. gillillg liS access 10 III ei,. patiellis alld 
providillg biopsy sall/ples. M.A.L. is Ille ,.ecipiellt oj a Poslgradllale FaCIl ity oj 
Medicille ScllOla,.sllip jimll tl,c UllillC,.sily oj Sydlley. 
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